Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
MARINOL®
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
Multiple sclerosis and stress.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment.
Yoga for multiple sclerosis: a systematic review and meta-analysis.
In Vivo Brain MR Imaging at Subnanoliter Resolution: Contrast and Histology.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Dilantin (phenytoin) Supplemental Approval Letter
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Is natalizumab overshooting its rebound?
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
The nocebo effect: A clinicians guide.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.

Pages